122 related articles for article (PubMed ID: 12684157)
1. False risk attribution results in misleading assessment of the relationship between suppression of ovulation and the effectiveness of the Yuzpe regimen for emergency contraception.
Mikolajczyk RT; Stanford JB
Contraception; 2003 Apr; 67(4):333-5; author reply 335-7. PubMed ID: 12684157
[No Abstract] [Full Text] [Related]
2. Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function.
Croxatto HB; Fuentealba B; Brache V; Salvatierra AM; Alvarez F; Massai R; Cochon L; Faundes A
Contraception; 2002 Feb; 65(2):121-8. PubMed ID: 11927114
[TBL] [Abstract][Full Text] [Related]
3. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
Letterie GS
Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
[TBL] [Abstract][Full Text] [Related]
4. Population-based evaluation of the effectiveness of two regimens for emergency contraception.
Leung VW; Soon JA; Lynd LD; Marra CA; Levine M
Int J Gynaecol Obstet; 2016 Jun; 133(3):342-6. PubMed ID: 26969148
[TBL] [Abstract][Full Text] [Related]
5. Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
Archer DF; Kovalevsky G; Ballagh SA; Grubb GS
Contraception; 2009 Sep; 80(3):245-53. PubMed ID: 19698816
[TBL] [Abstract][Full Text] [Related]
6. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.
Lee SM; Dunn S; Evans MF
Can Fam Physician; 1999 Mar; 45():629-31. PubMed ID: 10099801
[TBL] [Abstract][Full Text] [Related]
8. Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function.
Tirelli A; Cagnacci A; Volpe A
Contraception; 2008 May; 77(5):328-32. PubMed ID: 18402847
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
Duijkers IJ; Klipping C; Zimmerman Y; Appels N; Jost M; Maillard C; Mawet M; Foidart JM; Coelingh Bennink HJ
Eur J Contracept Reprod Health Care; 2015; 20(6):476-89. PubMed ID: 26394847
[TBL] [Abstract][Full Text] [Related]
10. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
Spona J; Elstein M; Feichtinger W; Sullivan H; Lüdicke F; Müller U; Düsterberg B
Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
[TBL] [Abstract][Full Text] [Related]
11. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
Elomaa K; Lähteenmäki P
Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
[TBL] [Abstract][Full Text] [Related]
12. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
13. Pituitary and ovarian function in women receiving hormonal contraception.
Cohen BL; Katz M
Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
[TBL] [Abstract][Full Text] [Related]
14. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
Spona J; Feichtinger W; Kindermann C; Moore C; Mellinger U; Walter F; Gräser T
Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211
[TBL] [Abstract][Full Text] [Related]
15. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
16. Ovarian activity during regular oral contraceptive use.
Crosignani PG; Testa G; Vegetti W; Parazzini F
Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
18. Assessment of two emergency contraceptive regimens in Iran: levonorgestrel versus the Yuzpe.
Farajkhoda T; Khoshbin A; Enjezab B; Bokaei M; Karimi Zarchi M
Niger J Clin Pract; 2009 Dec; 12(4):450-2. PubMed ID: 20329690
[TBL] [Abstract][Full Text] [Related]
19. A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
Kroll R; Seidman L; Ricciotti N; Howard B; Weiss H
Eur J Contracept Reprod Health Care; 2015; 20(4):249-58. PubMed ID: 25522805
[TBL] [Abstract][Full Text] [Related]
20. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial.
Ellertson C; Webb A; Blanchard K; Bigrigg A; Haskell S; Shochet T; Trussell J
Obstet Gynecol; 2003 Jun; 101(6):1160-7. PubMed ID: 12798518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
